Cargando…
541. Comparing Patients with Severe COVID-19 Who Improve to the Point of Discharge Following an Abbreviated Course (< 5 Days) of Remdesivir (RDV) Versus a Standard Course (≥5 Days)
BACKGROUND: The COVID-19 pandemic has negatively affected our healthcare system. Our hospitals have reached maximum capacity on several occasions. Because of the need to make beds available to new patients, some patients with severe COVID-19 who were on low flow O2 supplementation have been discharg...
Autores principales: | Pham, Huan, Chen, Qiaoling, Li, Aldon, Baghban, Adam, Cheruvanky, Anita, Faiad, Graciela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644185/ http://dx.doi.org/10.1093/ofid/ofab466.740 |
Ejemplares similares
-
524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge
por: Gee, Benjamin, et al.
Publicado: (2021) -
761. Sepsis Readmissions and Coding in Two Community Hospitals
por: Cheruranky, Anita, et al.
Publicado: (2019) -
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
por: Goldman, Jason D., et al.
Publicado: (2020) -
541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023) -
Transcriptome profiling confirmed correlations between symptoms and transcriptional changes in RDV infected rice and revealed nucleolus as a possible target of RDV manipulation
por: Yang, Liang, et al.
Publicado: (2014)